Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- Check3 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2, representing a minor system or editorial update and not a change to the study details or visible content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record now indicates recruitment is closed (no longer looking for participants). New sections to help readers understand the study and how to join were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated alongside a revision update to v3.6.0.SummaryDifference0.5%

- Check25 days agoChange DetectedA new revision tag, v3.5.5, was added and the previous v3.5.4 tag removed, signaling an update to the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision tag, Revision: v3.5.4, was added and the previous Revision: v3.5.3 was removed. This is a metadata update to the page's revision history and does not modify the study information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s footer version label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a non-content site update.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.